Home - Products - Endocrinology/Hormones - RAAS - Saralasin acetate(34273-10-4 free base)

Saralasin acetate(34273-10-4 free base)

CAS No. 39698-78-7

Saralasin acetate(34273-10-4 free base)( —— )

Catalog No. M24359 CAS No. 39698-78-7

Saralasin acetate is a Non-selective angiotensin II antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 254 In Stock
10MG 377 In Stock
25MG 614 In Stock
50MG 853 In Stock
100MG 1152 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Saralasin acetate(34273-10-4 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    Saralasin acetate is a Non-selective angiotensin II antagonist.
  • Description
    Saralasin acetate is a Non-selective angiotensin II antagonist.
  • In Vitro
    Saralasin acetate hydrate (1 nM, 48 or 72 h) inhibits cell growth in 3T3 and SV3T3 cells.Saralasin acetate hydrate (5 μM, 2h) restores Ito, fast (Fast-Inactivating Transient Outward K+ Current in Mouse Ventricle) and I K, slow (Slow-Inactivating Transient Outward K+ Current in Mouse Ventricl) to control levels in myocytes.Saralasin acetate hydrate (0.1-10 nM, 40 min) inhibits binding of FITC-Ang II to rat liver membrane preparation (used as the source of angiotensin receptors) with a Ki value of 0.32 nM for 74% of the binding sites and 2.7 nM for the remaining binding sites.Saralasin acetate hydrate (1 μM, perfused rat ovary in vitro) inhibits the ovulation rate versus control and reduces prostaglandin E2 and 6-keto-prostaglandin F1α levels. Cell Proliferation Assay Cell Line:3T3 and SV3T3 cells Concentration:1 nM Incubation Time:48 h, 72 h Result:Inhibited cell growth in 3T3 and SV3T3 cells and caused an increase of cellular renin concentration.
  • In Vivo
    Saralasin acetate hydrate (intravenous injection, 5-50μg/kg, a single dose) ameliorates the oxidative stress and tissue injury in cerulein-induced pancreatitis.Saralasin acetate hydrate (subcutaneous injection, 10 and 30 mg/kg, a single dose) increases serum renin activity (SRA) in normal, conscious rats, without markedly altering blood pressure or heart rate. Animal Model:Cerulein-induced acute pancreatitis rats modelDosage:5, 10, 20, and 50 μg/kg, a single dose.Administration:Intravenous injection Result:Restored the pancreatic morphological characteristics to the control level.Reduced pancreatic injury and suppressed the glutathione depletion induced by cerulean.Animal Model:Male Sprague-Dawley rats Dosage:10 and 30 mg/kg, a single dose.Administration:Subcutaneous injection Result:Stimulated renin release without altering blood pressure or heart rate at the time of measuring serum renin levels 20 minutes after injection.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    angiotensin II receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39698-78-7
  • Formula Weight
    990.11
  • Molecular Formula
    C44H71N13O13
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)[C@@H](C(N[C@@H](Cc1cnc[nH]1)C(N(CCC1)[C@@H]1C(N[C@@H](C)C(O)=O)=O)=O)=O)NC([C@H](Cc(cc1)ccc1O)NC([C@H](C(C)C)NC([C@H](CCCN=C(N)N)NC(CNC)=O)=O)=O)=O.CC(O)=O.O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Thomas GP, Howlett SE, Ferrier GR. Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion. J Pharmacol Exp Ther. 1995 Sep;274(3):1379-86.
molnova catalog
related products
  • Prosaikogenin G

    Prosaikogenin G is a compound isolated from the roots of Buleurum bicaule Helm (Apiaceae) and id a derivative of Saikosaponin d in the gastrointestinal tract, exhibiting a significant inhibitory effect on angiotensin II-induced proliferation of mesangial

  • Ramiprilat

    Ramiprilat is an angiotensin-converting enzyme (ACE) inhibitor?with antihypertensive activity.

  • Alunacedase alfa

    Alunacedase alfa (APN-01) is a soluble angiotensin-converting enzyme 2 (hrsACE2) with antiviral activity that reduces the competitive entry of SARS-CoV-2 into cell membranes bound to ACE2.